drugset / Trial / NCT01392820

A Study of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female Volunteers

NCT01392820

Phase 1 Completed 48 enrolled AstraZeneca
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The purpose of this study is to assess safety, tolerability and pharmacokinetics of TC-5214 in elderly healthy Japanese volunteers.

Timeline

Start
2011-07
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject dexmecamylamine Other / unclassified Oral

Indications

No indication recorded.